Latest 杨贵妃传媒視頻 Health News Stories
This State Isn鈥檛 Waiting for Biden To Negotiate Drug Prices
As the federal government negotiates with drugmakers to lower the price of 10 expensive drugs for Medicare patients, impatient legislators in some states are trying to go even further. Leading the pack is Colorado, where a new Prescription Drug Affordability Review Board is set to recommend an 鈥渦pper payment limit鈥 for drugs it deems unaffordable. In late […]
At Stake in Mifepristone Case: Abortion, FDA鈥檚 Authority, and Return to 1873 Obscenity Law
The end goal for a conservative Christian group鈥檚 mifepristone case before the Supreme Court: a de facto nationwide abortion ban.
A Paramedic Was Skeptical About This Rx for Stopping Repeat Opioid Overdoses. Then He Saw It Help.
For years, addiction response teams have traveled around Florida to connect people who have overdosed with resources and recovery centers. Now, a handful have a new tool in their kit: buprenorphine, which can help prevent the cravings and withdrawal symptoms that lead to more drug use.
Journalists Track Efforts to Curb the Opioid Crisis and Put Catholic Hospitals Under the Scope
杨贵妃传媒視頻 Health News and California Healthline staff made the rounds on national and local media in recent weeks to discuss their stories. Here鈥檚 a collection of their appearances.
杨贵妃传媒視頻 Health News' 'What the Health?': The ACA Turns 14
Saturday marks the 14th anniversary of the still somewhat embattled Affordable Care Act. Health and Human Services Secretary Xavier Becerra joins host Julie Rovner to discuss the accomplishments of the health law 鈥 and the challenges it still faces. Also this week, Alice Miranda Ollstein of Politico, Tami Luhby of CNN, and Mary Agnes Carey of 杨贵妃传媒視頻 Health News join Rovner to discuss what should be the final funding bill for HHS for fiscal 2024, next week鈥檚 Supreme Court oral arguments in a case challenging abortion medication, and more. Plus, for 鈥渆xtra credit,鈥 the panelists suggest health policy stories they read this week they think you should read, too.
A Battle Between Drugmakers and Insurers Hits Patients in the Wallet
There鈥檚 a long-running battle between insurers and drugmakers over financial assistance programs that purport to help patients afford expensive drugs. And lately, insurers have been losing ground as lawmakers, regulators and courts weigh in. The issue is whether coupons and other copay aid many patients get from drugmakers should count toward annual insurance deductibles and […]
Watch: Many Americans Are Unaware of HIV Prevention Medication
Some Americans mistakenly believe medication to prevent HIV transmission through sex is just for certain groups such as gay men, but anyone who鈥檚 at risk for contracting HIV through sex could benefit.
When Copay Assistance Backfires on Patients
Drugmakers offer copay assistance programs to patients, but insurers are tapping into those funds, not counting the amounts toward patient deductibles. That leads to unexpected charges. But the practice is under growing scrutiny.
杨贵妃传媒視頻 Health News' 'What the Health?': Maybe It鈥檚 a Health Care Election After All
Health care wasn鈥檛 expected to be a major theme for this year鈥檚 elections. But as President Joe Biden and former President Donald Trump secured their respective party nominations this week, the future of both Medicare and the Affordable Care Act appears to be up for debate. Meanwhile, the cyberattack of the UnitedHealth Group subsidiary Change Healthcare continues to do damage to the companies鈥 finances with no quick end in sight. Margot Sanger-Katz of The New York Times, Anna Edney of Bloomberg News, and Joanne Kenen of Johns Hopkins University and Politico Magazine join 杨贵妃传媒視頻 Health News鈥 Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Kelly Henning of Bloomberg Philanthropies about a new, four-part documentary series on the history of public health, 鈥淭he Invisible Shield.鈥 Plus, for 鈥渆xtra credit鈥 the panelists suggest health policy stories they read this week that they think you should read, too.
Ya hay una droga oral para la depresi贸n postparto鈥 pero cuesta $16,000
Abogados, defensores y reguladores est谩n observando de cerca c贸mo las aseguradoras dise帽ar谩n las normas para cubrirlo.
A New $16,000 Postpartum Depression Drug Is Here. How Will Insurers Handle It?
A pill form of an effective drug for postpartum depression hit the market in December, but most insurers do not yet have a policy on when or whether they will pay for it. The hurdles to obtain its predecessor medication have advocates worried.
Colorado Isn鈥檛 Giving up on Its Drug Importation Dream
Colorado hopes to join Florida to become only the second state authorized to import prescription drugs from Canada. But they鈥檙e hitting the same hurdles: drugmakers 鈥 and the FDA. Colorado officials recently amended their 2022 importation application with the Food and Drug Administration, in the process revealing new correspondence that shows the state鈥檚 so-far fruitless […]
Why Covid Patients Who Could Most Benefit From Paxlovid Still Aren鈥檛 Getting It
Price worries, bureaucratic obstacles, and 鈥淚鈥檓-over-covid-itis鈥 slow uptake of a drug that鈥檚 complicated to take but often effective.
杨贵妃传媒視頻 Health News' 'What the Health?': The State of the Union Is … Busy
At last, Congress is getting half of its annual spending bills across the finish line, albeit five months after the start of the fiscal year. Meanwhile, President Joe Biden delivers his annual State of the Union address, an over-the-counter birth control pill is (finally) available, and controversy erupts over new public health guidelines for covid-19 isolation. Alice Miranda Ollstein of Politico, Sarah Karlin-Smith of the Pink Sheet, and Sandhya Raman of CQ Roll Call join 杨贵妃传媒視頻 Health News鈥 Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Neera Tanden, the White House domestic policy adviser, about Biden鈥檚 health agenda. Plus, for 鈥渆xtra credit,鈥 the panelists suggest health policy stories they read this week that they think you should read, too.
Journalists Examine Medicaid Unwinding, Farmworkers’ Mental Health, and the Big Opioid Payback
杨贵妃传媒視頻 Health News and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here鈥檚 a collection of their appearances.
Los amigos de un joven muerto por envenenamiento por fentanilo impulsan una ley estatal para que estudiantes de secundaria puedan llevar Narcan en sus mochilas sin riesgo de ser castigados.
How a Friend鈥檚 Death Turned Colorado Teens Into Anti-Overdose Activists
High school students in Colorado are pushing for a change they say is necessary to combat fentanyl poisoning: ensuring students can’t get in trouble for carrying the overdose reversal drug naloxone wherever they go, including at school.
An Arm and a Leg: Wait, Is Insulin Cheaper Now?
Did the price of insulin go down? It鈥檚 not quite that simple. On this episode of 鈥淎n Arm and a Leg,鈥 producer Emily Pisacreta explores recent changes to the cost of the diabetes medication.
Patients See First Savings From Biden鈥檚 Drug Price Push, as Pharma Lines Up Its Lawyers
A restructuring of the Medicare drug benefit has wiped out big drug bills for people who need expensive medicines. But the legal battle over drug negotiations means uncertainty over long-term savings.
杨贵妃传媒視頻 Health News' 'What the Health?': Biden Wins Early Court Test for Medicare Drug Negotiations
A federal district court judge dismissed a lawsuit attempting to invalidate the Biden administration鈥檚 Medicare prescription-drug price negotiation program. But the suit turned on a technicality, and several more court challenges are in the pipeline. Meanwhile, health policy pops up in Super Bowl ads, as Congress approaches yet another funding deadline. Alice Miranda Ollstein of Politico, Lauren Weber of The Washington Post, and Rachel Cohrs of Stat join 杨贵妃传媒視頻 Health News鈥 Julie Rovner to discuss these issues and more. Plus, for 鈥渆xtra credit,鈥 the panelists suggest health policy stories they read this week they think you should read, too.
